The lactose intolerance market, estimated to be valued at USD 11.53 Billion in 2025, is projected to exhibit a CAGR of 6.4%, reaching USD 17.80 Billion by 2032. This growth is driven by the rising consumer awareness of lactose intolerance and increasing prevalence of lactose malabsorption globally.

Demand for lactose-free and dairy alternative products is surging, fueled by health-conscious dietary shifts and innovations in plant-based formulations. Additionally, improvements in diagnostic tools and the growing availability of enzyme-based supplements are supporting better disease management. Expanding retail penetration of lactose-free products and increasing focus on digestive health across both developed and emerging markets are further expected to bolster the market growth over the forecast period.

Market Takeaways

• By Product Type, the Lactose-free Dairy Products segment is projected to dominate the market with a 41.2% share in 2025, driven by strong consumer demand for conventional dairy alternatives that retain taste and nutritional value without triggering intolerance symptoms.
• By End User, the Adults segment is expected to hold the largest market share at 42.9% in 2025, attributed to the higher diagnosis rate of lactose intolerance in adults and their increased consumption of lactose-reduced or enzyme-supported products.
• By Distribution Channel, Supermarkets/Hypermarkets are anticipated to lead the market with a 43.1% share in 2025, owing to the broad shelf presence of lactose-free products and growing consumer preference for convenient one-stop retail purchases.
• By Region, North America is expected to account for the largest share in 2025, supported by heightened consumer awareness, widespread availability of dairy alternatives, and robust investments in product innovation and retail distribution networks.

Lactose Intolerance Market Report Coverage

The full report is now available for purchase: https://www.coherentmi.com/industry-reports/lactose-intolerance-market

Market Dynamics

The Lactose Intolerance market is experiencing steady growth, driven by the increasing global prevalence of lactose malabsorption and rising consumer awareness regarding digestive health. As dietary patterns shift toward more health-conscious choices, demand for lactose-free dairy products, enzyme-based supplements, and non-dairy alternatives has surged. This trend is further amplified by the expanding adoption of plant-based nutrition and the rising number of consumers self-diagnosing or proactively managing symptoms of intolerance.

Technological advancements in food processing—such as improved lactase enzyme formulations and microfiltration techniques—are enhancing the quality and taste of lactose-free products, encouraging broader adoption. Additionally, product innovations such as fortified lactose-free milk, flavored dairy alternatives, and ready-to-drink supplements are diversifying offerings and attracting new consumer segments.

The market is also benefiting from the expansion of retail distribution channels, particularly supermarkets/hypermarkets and online platforms, which are increasing the accessibility and visibility of lactose-intolerance-specific products.

Moreover, growing investments in R&D by key players are fueling the development of more effective lactase supplements and gut-friendly solutions. Regional dietary sensitivities, particularly in Asia-Pacific and Latin America—where lactose intolerance prevalence is high—are also contributing to accelerated product uptake and market expansion.

In June 2022, Provilac, one of the fastest-growing neo-age premium milk delivery firms in India, announced the launch of lactose-free cow milk. Lactose-free milk is a huge addition to the company’s already existing portfolio of milk and its byproducts. Provilac is already serving 20,000 households in Pune, Mumbai, and Hyderabad. The company, being a completely tech-enabled start-up, is revolutionizing the dairy industry with its state-of-the-art tech platform, its cold supply chain that helps manage the integrity of milk, and state-of-the-art farms.

Market Trends

• Precision Fermentation is Redefining Lactose-Free Dairy Proteins

Emerging biotech innovations like precision fermentation are transforming the landscape of lactose-free dairy. Companies such as Perfect Day, Remilk, and Imagindairy are using microbes to produce animal-identical whey and casein proteins without lactose, enabling the creation of dairy products that taste and perform like traditional milk—minus the digestive discomfort. These proteins are increasingly being integrated into lactose-free ice creams, yogurts, and creamers, appealing to both lactose-intolerant and environmentally conscious consumers.

For instance, in May 2022, Tomorrow Farms launched Bored Cow, a bioidentical milk alternative using Perfect Day’s precision‑fermented whey protein. This product debuted directly to consumers with dairy-equivalent taste and functionality—yet completely lactose‑free. This trend is accelerating due to growing investments and regulatory approvals, especially in North America and parts of Europe.

• Fortified Lactose-Free Products Gaining Momentum Among Health-Conscious Consumers

There is a growing consumer shift toward fortified lactose-free dairy and plant-based products enriched with vitamins (B12, D), calcium, and probiotics. Brands like Danone, Nestlé Health Science, and Lactaid are launching fortified milk and yogurt alternatives that not only cater to lactose intolerance but also support gut health and immunity. The fusion of digestive comfort with functional nutrition is driving product differentiation and encouraging premium pricing strategies in both mature and emerging markets.

In November 2023, Nestlé announced that it had developed N3 milk. Made from cow's milk, it has all the essential nutrients found in milk, such as proteins, vitamins, and minerals. In addition, it contains prebiotic fibers, has a low lactose content, and has over 15% fewer calories.

To develop the N3 milk, Nestlé used a proprietary technology to reduce lactose - a sugar found in cow's milk - through specialized enzymes, thereby generating beneficial prebiotic fibers. Clinical studies showed that these fibers promote the growth of multiple types of bifidobacteria by up to threefold, delivering gut microbiome benefits in healthy adults.

Market Opportunities

• Expansion of Lactose-Free Functional Foods Beyond Dairy

There is a growing opportunity to expand lactose-free innovation into broader functional food categories such as nutritional bars, meal replacement drinks, and infant cereals and weaning foods. As consumers increasingly seek multi-functional, on-the-go nutrition solutions, there is a rising demand for products that combine digestive comfort with added benefits like protein, essential vitamins, and gut health support. This shift opens the door for lactose-free formulations beyond traditional dairy, targeting busy lifestyles and health-focused eating habits.

One notable example of this trend occurred in July 2022, when Danone announced the launch of the world’s first Dairy and Plants Blend baby formula. This innovation was developed in response to the growing consumer preference for vegetarian and flexitarian diets, especially among parents. According to a Danone-conducted survey, over one-third (37%) of EU consumers now follow a vegan, vegetarian, or flexitarian diet, and nearly 70% of parents prefer their children to consume more plant-based foods. Danone’s plant-dairy formula caters to this evolving nutritional demand while also addressing lactose sensitivity, highlighting how infant nutrition is becoming a key frontier in the lactose-free functional food landscape.

• Personalized Nutrition & Microbiome-Targeted Lactose Solutions

The growing adoption of personalized nutrition platforms and gut microbiome diagnostics is creating significant opportunities within the lactose intolerance market. Innovations in DNA-based intolerance assessments, probiotic-enriched lactose-free products, and tailored lactase enzyme supplements are enabling more targeted and effective digestive health strategies. These solutions are particularly appealing to consumers seeking to manage lactose intolerance through personalized dietary planning and functional interventions.

One notable example is the rise of DNA testing kits that analyze genetic markers like the MCM6 gene to determine lactase persistence. These tests offer tailored dietary insights and are increasingly bundled with lactose-free meal plans and supplement recommendations. Similarly, advancements in gut microbiome research are supporting the development of probiotic-infused lactose-free products that promote long-term digestive comfort by improving microbial balance and enhancing lactose metabolism.

In June 2025, DairyPill introduced a next-generation ultra-potent lactase enzyme supplement, delivering 18,000 FCC units per pill—approximately six times stronger than standard formulations. The product is packaged in a convenient keychain-style dispenser, designed for portability and single-meal use. This innovation addresses the needs of consumers who require fast-acting, on-the-go digestive support during travel, dining out, or in everyday scenarios. Such high-performance, lifestyle-oriented supplements reflect the increasing consumer demand for personalized and practical solutions that fit seamlessly into daily routines.

Analyst View

• The lactose intolerance market is undergoing a dynamic transformation as consumer demand rapidly shifts toward personalized, functional, and convenience-driven digestive health solutions. With growing global awareness of lactose malabsorption and associated symptoms, the market is no longer limited to basic dairy substitutes—it's expanding into fortified nutrition, DNA-informed dietary planning, and enzyme-based therapies that address intolerance at the root cause.
• Key players are innovating aggressively, blending biotechnology with consumer insights to launch potent lactase supplements, precision-fermented dairy proteins, and microbiome-friendly dairy alternatives. This convergence of diagnostics, supplements, and functional food offerings is reshaping the lactose-free ecosystem into a comprehensive digestive health platform.
• Technological advancements such as precision fermentation and smart enzyme delivery systems are not only elevating product performance but also expanding the scope of lactose-free offerings into adjacent segments like infant nutrition, meal replacements, and functional beverages. The emergence of portable, high-dosage enzyme formats like DairyPill exemplifies how convenience and potency are becoming pivotal for consumer adoption.
• From a regional standpoint, North America and Asia Pacific are expected to drive significant growth, with the former benefiting from innovation pipelines and established retail infrastructure, and the latter presenting untapped potential due to high genetic prevalence of lactose intolerance and growing health-conscious middle-class consumers.
• Overall, the market is transitioning from reactive symptom relief to proactive, science-backed digestive wellness, with personalization, portability, and gut microbiome integration acting as key differentiators. Stakeholders investing in diagnostics-integrated product strategies, precision nutrition, and fortified lactose-free innovations are well-positioned to lead in this evolving landscape.

Key Developments

• In April 2025, DSM-Firmenich, a global innovator in health, nutrition, and beauty, announced the approval of its human milk oligosaccharide (HMO), 2'-O-Fucosyllactose (2'-FL)—commercially known as GLYCARE 2FL—as a functional ingredient for early life nutrition in India. 
• In December 2023, Kerry Group plc, the global taste & nutrition company, announced that it had entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S (“Chr. Hansen”) and Novozymes A/S (“Novozymes”) (together the “Lactase Enzymes Business”) on a carve-out basis. This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process.

Competitive Landscape

• CHR Hansen Holdings A/S
• Kerry Group plc.
• Koninklijke DSM N.V.
• Novozymes A/S
• International Flavors & Fragrances Inc.
• Merck
• Amano Enzyme
• Advanced Enzyme Technologies
• Novact Corporation
• Antozyme Biotech Pvt. Ltd

Lactose Intolerance Market Segmentation

• By Product Type
• Lactose-free Dairy Products
• Lactase Supplements
• Non-dairy Alternatives
• By End User
• Adults
• Children
• Infants
• By Distribution Channel
• Supermarkets/Hypermarkets
• Online Retail
• Health Food Stores
• Pharmacies

Regional Insights

• North America
  • U.S.
  • Canada
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe
  • Italy
  • Germany
  • U.K.
  • Spain
  • France
  • Russia
  • Rest of Europe
• Asia Pacific
  • South Korea
  • India
  • Japan
  • China
  • Australia
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa